EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression

다국어 초록 (Multilingual Abstract)

Background Early growth response-1 (EGR1) is a transcription factor involved in the progression of several cancer types.
However, the expression and clinical signifcance of EGR1 in uterine cervical cancer (CC) have not been elucidated.
Objective To investigate the expression, clinical signifcance and prognostic value of EGR1 in CC.
Methods The expression of EGR1 was detected in 13 CCs and paired adjacent tissues with qRT-PCR and in 144 CC tissues with immunohistochemistry (IHC). The IHC scores were used to divide the patients into subsets with low and high EGR1 expression. The correlations between the EGR1 expression and clinicopathological factors were analyzed with the chi-square test, and the prognostic signifcance of EGR1 expression was evaluated with univariate and multivariate analyses. The functions of EGR1 in the proliferation, invasion and stemness of CC cells were investigated, and the molecular mechanism was assessed by in vitro experiments.
Results High expression of EGR1 was signifcantly associated with low survival rates of CC. EGR1 is an independent prognostic biomarker of CC, and its high expression predicted a poor outcome. EGR1 facilitated stemness and thus promoted proliferation and invasion of CC cells. SOX9 played an essential role in the EGR1-induced progression of CC cells.
Conclusions EGR1 is an independent prognostic biomarker of CC. High EGR1 expression promoted proliferation, invasion and stemness by increasing SOX9 expression in CC cells. Our results suggested that the EGR1-SOX9 axis may be a potential drug target and that blocking the EGR1-SOX9 axis may be a possible approach to treating CC.

참고문헌 (Reference)

1 Silverman ES, "cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1)" 336 (336): 183-189, 1998

2 Wang L, "Unbalanced YAP-SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma" 38 : 2042-2055, 2019

3 Marquina G, "Targeted agents in cervical cancer : beyond bevacizumab" 20 : 40-, 2018

4 Crawford NT, "TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells" 38 : 5971-5986, 2019

5 Ma L, "Suppressing serum response factor inhibits invasion in cervical cancer cell lines via regulating Egr1 and epithelial-mesenchymal transition" 43 : 614-620, 2019

6 Yang M, "Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1" 158 : 277-286, 2016

7 Zhang F, "Specifc interaction of Egr1 and c/EBPbeta leads to the transcriptional activation of the human low density lipoprotein receptor gene" 278 : 44246-44254, 2003

8 Dy P, "Sox9 directs hypertrophic maturation and blocks osteoblast diferentiation of growth plate chondrocytes" 22 : 597-609, 2012

9 Leung CO, "Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/beta-catenin signaling" 7 : 29371-29386, 2016

10 Finzsch M, "Sox9 and Sox10infuence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression" 135 : 637-646, 2008

11 Feng C, "SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell" 17 : 448-458, 2018

12 Wang HY, "SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth" 6 : 20711-20722, 2015

13 Wang H, "SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion" 68 : 1625-1630, 2008

14 Jana S, "SOX9 : The master regulator of cell fate in breast cancer" 174 : 113789-, 2020

15 Tang T, "Protease Nexin I is a feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast cancer cells metastasis and stemness" 10 : 649-, 2019

16 Liu J, "Physical interaction between p53 and primary response gene Egr-1" 18 : 863-870, 2001

17 Burki TK, "Novel mutations in cervical cancer" 18 : e137-, 2017

18 Liu CQ, "MicroRNA-215-3p suppresses the growth and metastasis of cervical cancer cell via targeting SOX9" 23 : 5628-5639, 2019

19 Gao C, "MicroRNA expression in cervical cancer : Novel diagnostic and prognostic biomarkers" 119 : 7080-7090, 2018

20 Qu H, "Melatonin inhibits osteosarcoma stem cells by suppressing SOX9-mediated signaling" 207 : 253-264, 2018

21 Hasen NS, "Maternal aggression : new insights from Egr-1" 1108 : 147-156, 2006

22 Chen Y, "MAFB promotes cancer stemness and tumorigenesis in osteosarcoma through a Sox9-mediated positive feedback loop" 80 : 2472-2483, 2020

23 Chen DG, "Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter" 36 : 186-, 2017

24 Falconi G, "Impairment of PI3K/AKT and WNT/beta-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes" 44 (44): e71-e74, 2016

25 Berent TE, "Impaired cardiac performance, protein synthesis, and mitochondrial function in tumorbearing mice" 14 : e0226440-, 2019

26 Michelle K. Y. Siu, "Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades" MDPI AG 11 (11): 813-, 2019

27 Torre LA, "Global cancer statistics, 2012" 65 : 87-108, 2015

28 Zhiqiang Hu, "Gentiopicroside Inhibits Cell Growth and Migration on Cervical Cancer via the Reciprocal MAPK/Akt Signaling Pathways" Informa UK Limited 73 (73): 1459-1470, 2021

29 Zhang L, "Expression of USP7 and MARCH7 is correlated with poor prognosis in epithelial ovarian cancer" 239 : 165-175, 2016

30 Yang SZ, "Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgendepleted environment" 97 : 1292-1299, 2006

31 Yang SZ, "Early growth response gene 1 modulates androgen receptor signaling in prostate carcinoma cells" 278 : 39906-39911, 2003

32 Li L, "EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis" 38 : 6241-6255, 2019

33 Parra E, "Down-regulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3" 22 : 1513-1518, 2009

34 Pagel JI, "Disease progression mediated by egr-1associated signaling in response to oxidative stress" 13 : 13104-13117, 2012

35 Huang RP, "Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation" 72 : 102-109, 1997

36 Chen W, "Cancer statistics in China, 2015" 66 : 115-132, 2016

37 Yagi R, "Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway" 280 : 30517-30525, 2005

38 Simpson S, "Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22. 2-22. 3 in immortal and cervical carcinoma cell lines" 14 : 2149-2157, 1997

39 Sakakini N, "A positive feed-forward loop associating EGR1 and PDGFA promotes proliferation and self-renewal in glioblastoma stem cells" 291 : 10684-10699, 2016

40 Shan J, "A mitogen-activated protein kinase/extracellular signal-regulated kinase kinase(MEK)-dependent transcriptional program controls activation of the early growth response 1(EGR1)gene during amino acid limitation" 289 : 24665-24679, 2014

41 Mi Zhou, "12-Deacetyl-12-epi-Scalaradial, a Scalarane Sesterterpenoid from a Marine Sponge Hippospongia sp., Induces HeLa Cells Apoptosis via MAPK/ERK Pathway and Modulates Nuclear Receptor Nur77" MDPI AG 18 (18): 375-, 2020